Company Profiles

driven by the PitchBook Platform

Abpro

Description

Developer of therapeutic antibody technology intended to target human disease. The company's DiversImmuneTM platform leverages synthetic biology and immunology to generate therapeutic antibodies against novel and challenging targets, enabling biotechnology and pharmaceutical companies to develop many therapeutic antibodies against traditionally difficult targets.

2007

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$10M

Latest Deal Amount

$29.4M

Total Amount Raised

Description

Developer of therapeutic antibody technology intended to target human disease. The company's DiversImmuneTM platform leverages synthetic biology and immunology to generate therapeutic antibodies against novel and challenging targets, enabling biotechnology and pharmaceutical companies to develop many therapeutic antibodies against traditionally difficult targets.

Website:

www.abpro-labs.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Other Healthcare Services

Primary Office

65 Cummings Park Drive Woburn, MA 01801United States +1 (800) 396-5890
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Abpro's full profile, request a free trial.

Abpro Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Abpro Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Abpro Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AngelVest GroupAngel GroupMinority000 0000000 0000
Essex Bio-technologyCorporationMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
AngelVest Group Angel Group
Essex Bio-technology Corporation
Individual Investor Angel (individual)

Abpro Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Ian ChanCo-Founder, Chief Executive Officer & Chairman
Adam MostafaChief Financial Officer
Gavin MacBeath Ph.DChief Scientific Officer
Jessie Wong Ph.DDirector, Business Development
Eugene Chan MDCo-Founder, Chief Scientific Officer, Scientific Advisor & Vice Chairman
Ian Chan Co-Founder, Chief Executive Officer & Chairman
Adam Mostafa Chief Financial Officer
Gavin MacBeath Ph.D Chief Scientific Officer
Jessie Wong Ph.D Director, Business Development
Eugene Chan MD Co-Founder, Chief Scientific Officer, Scientific Advisor & Vice Chairman

Abpro Board Members (6)

NameRepresentingRoleSinceContact
Info
Benjamin HaAbproBoard Member000 0000
Bob LangerAbproBoard Member000 0000
Eugene Chan MDSelfCo-Founder, Chief Scientific Officer, Scientific Advisor & Vice Chairman000 0000
Frank YeAbproBoard Member000 0000
Ian ChanAbproCo-Founder, Chief Executive Officer & Chairman000 0000
Benjamin Ha Board Member Abpro
Bob Langer Board Member Abpro
Eugene Chan MD Co-Founder, Chief Scientific Officer, Scientific Advisor & Vice Chairman Self
Frank Ye Board Member Abpro
Ian Chan Co-Founder, Chief Executive Officer & Chairman Abpro
Request full access to PitchBook